Cancer is the most critical disease that has affected humanity through history. It is very dangerous due to the lack of treatment and the various different cancers out there. It gets hard to find treatments that are not destructive to the human body.
Adding insult to injury, a new study has observed that bowel cancer can actually change its position and spots as a defensive mechanism from the immunotherapy. This is done by having the cell structure and surface broken down by turning off a molecules. This can be very dangerous as undetected cancer can form tumors that will increase in size thus increasing the risk of the cancer.
This was observed through a new study conducted by a team of researchers from The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, where they suggest that a change in their treatment might help fight against the deciving move done by bowel cancer. They have developed a treatment called cibisatamab which can actually be amended to increase its effectiveness.
The study was led by a Team Leader in Translational Oncogenomics at The Institute of Cancer Research, London, and Consultant Oncologist at The Royal Marsden, Dr. Marco Gerlinger, who commented saying, “Cancer is very good at hiding from the body’s immune system. The latest successful immunotherapies work by acting as a matchmaker to bring the immune system together with cancer, so that it can see it and attack it.”